It is now well established that the immune system is able to detect and destroy tumors in a process termed tumor immunosurveillance. However, the "dark side" of tumor immunity is immune evasion. That is, by the time a patient suffers from a clinically-detectable tumor, the tumor has already successfully evaded cancer immunosurveillance and often has established effective mechanisms to actively suppress the immune system, particularly in the tumor microenvironment. Therefore, cell contact-dependent and -independent immunosuppressive networks represent a significant barrier to effective immunity and immunotherapy. In this chapter, we describe some of these immunosuppressive mechanisms and components that are linked in complex networks. A better understanding of these mechanisms will eventually lead to improvements of cancer immunotherapies.
CITATION STYLE
Zimmermann, W., & Kammerer, R. (2011). Negative regulators in cancer immunology and immunotherapy. In Experimental and Applied Immunotherapy (pp. 229–249). Humana Press Inc. https://doi.org/10.1007/978-1-60761-980-2_11
Mendeley helps you to discover research relevant for your work.